- Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
- Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
- Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
- Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
More ▼
Key statistics
On Friday, Conduit Pharmaceuticals Inc (CDT:NMQ) closed at 2.97, 212.63% above the 52 week low of 0.95 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.82 |
---|---|
High | 3.05 |
Low | 2.66 |
Bid | 2.45 |
Offer | 3.50 |
Previous close | 2.94 |
Average volume | 25.20k |
---|---|
Shares outstanding | 73.83m |
Free float | 10.87m |
P/E (TTM) | -- |
Market cap | 228.13m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼